| Brock P Whittenberger, MD | |
|
801 N 29th St, Billings, MT 59101-0905 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Brock P Whittenberger |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 801 N 29th St, Billings, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033293444 | NPI | - | NPPES |
| 17263 | Other | ND | ND BCBS |
| 0111010 | Other | MT | MDCD PIN |
| 101787000 | Other | WY | MDCD PIN |
| 000004741 | Other | MT | BCBS PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 7246 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brock P Whittenberger, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Brock P Whittenberger, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500 |
News Archive
Scientists from Tomsk Polytechnic University with colleagues from Great Britain Germany, China, and Switzerland have proposed a new way of delivering anti-thrombosis drugs to the damaged areas of the blood vessels.
The Obama administration has opted to delay for some plans a health law provision that caps consumers' out-of-pocket exposure.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement") with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.
Leaders in biomedical education at Johns Hopkins University School of Medicine are calling for a radical new approach to post-graduate training in the life sciences to address significant challenges, including an avalanche of new discoveries in the last decade and the need to transcend traditional departmental boundaries to understand biological processes at multiple levels.
› Verified 9 days ago
Charles Wittnam, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500 | |
Phillip Embury Griffin, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2938 Rockrim Ln, Billings, MT 59102 Phone: 406-259-7582 | |
Megan B Littlefield, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Charles Mcclave, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N, Suite 160w, Billings, MT 59101 Phone: 406-237-8500 Fax: 406-237-8501 | |
Karen C. Klee, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Benjamin Girton Plank, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |